Older mice who are surgically joined with young mice in order to share a common bloodstream get stronger and healthier, making parabiosis one of the hottest topics in age research.
Publishing in Nature Metabolism, researchers from the Buck Institute report that MANF (mesencephalic astrocyte-derived neurotrophic factor) is one of the factors responsible for rejuvenating the transfused older mice. Researchers also show the naturally-occurring, evolutionarily-conserved repair mechanism protects against liver damage in aging mice and extends lifespan in flies.
“We know that MANF, which regulates metabolism and immune response in flies, mice and humans, declines with age,” said senior author Heinrich Jasper, PhD, a Buck professor and staff scientist at Genentech. “This research shows that replenishing MANF has promise as an anti-aging treatment although much work remains to be done in order to understand its mechanism of action.”
While researchers have yet to understand why MANF levels decrease with age, Jasper says MANF deficiency has obvious hallmarks. Flies genetically engineered to express less MANF suffered from increased inflammation and shorter lifespans. MANF-deficient mice had increased inflammation in many tissues as well as progressive liver damage and fatty liver disease. Older mice who shared blood with MANF-deficient younger mice did not benefit from the transfusion of young blood
Buck postdoctoral fellows Pedro Sousa-Victor, PhD, and Joana Neves, PhD, were co-leaders of the study. They zeroed in on MANF and its impact on the liver and metabolism. They found that liver rejuvenation spurred by parabiosis was dependent on MANF. In addition, they showed that supplementing MANF in aging mice slowed liver aging, prevented fatty liver disease in animals on a high fat diet and improved age-related metabolic dysfunction.
“MANF appears to regulate inflammatory pathways that are common to many age-related diseases,” said Neves. “We are hoping its effects extend beyond the liver, we plan to explore this in other tissues.”
“The search for systemic treatments that would broadly delay or prevent age-related diseases remains the holy grail of research in aging,” said Jasper. “Given that MANF appears to modulate the immune system, we are excited to explore the larger implications of its therapeutic use. We are also cautious. There are many tissues and organ systems to evaluate in terms of MANF and we have yet to determine its effects on lifespan in the mouse.”
The Latest on: Parabiosis
via Google News
The Latest on: Parabiosis
- Immune Recognition and Rejection of Allogeneic Skin Graftson September 13, 2022 at 5:00 pm
Following placement of skin allografts, donor DCs, often referred to as passenger leukocytes, migrate out of the graft through lymphatic vessels and infiltrate the recipient's draining lymph nodes ...
- Core B Procedure and Service Chargeson September 9, 2022 at 3:35 pm
(8-day exp. each animal) / $828 (10-day exp. each animal) / $891.80 (15-d exp. each animal) / $1051.30 (30-day exp. each animal) / $1529.80 ...
- The thirst for young blood: does young blood reverse aging?on September 7, 2022 at 9:00 am
More than 200 hundred years ago, scientists began surgically joining young organisms with older organisms in a process known as heterochronic parabiosis to see what happened when the animals shared a ...
- From Inequality to Immortalityon August 25, 2022 at 5:00 pm
Today, this procedure goes by the innocuous-sounding name parabiosis – a surgical union of two organisms sharing the circulation of blood. And the search for the fountain of youth continues. There is ...
- Joe Betts-LaCroix to present at the 9th Aging Research & Drug Discovery Meeting 2022on August 18, 2022 at 1:22 pm
August 19, 2022 – Joe Betts-LaCroix PhD, will present the latest research on the topic What do reprogramming, parabiosis, and autophagy have in common? at the world’s largest annual Aging ...
- A transfusion of 'old' blood might make you age more quicklyon August 14, 2022 at 7:20 pm
The process is known as heterochronic parabiosis and, shockingly, isn’t all that new. The process of surgically connecting two organisms dates back at least 150 years and the specific version of ...
- First Results of a Clinical Trial to "Cure Aging" Using Young Blood Just Came inon August 7, 2022 at 5:00 pm
The idea of injecting plasma to combat the effects of aging comes from a 19th-century concept that's now referred to as parabiosis. In its earliest iteration, the skin of old and young mice was ...
- If Young Blood Can Combat Aging, It May Be Thanks to Just One Proteinon April 2, 2017 at 2:23 am
Ambrosia, a company inspired by the work done by Stanford University neuroscientist Tony Wyss-Coray with parabiosis in mice, charges $8,000 per patient for its human clinical trial of parabiosis.
- A historical perspective on leptinon October 1, 2010 at 5:00 am
Fortunately, two of my colleagues at the Jackson Laboratory were using parabiosis to characterize anemia mutant mice and were pleased to instruct me in this technique. Parabiosis requires the ...
- Migration, maintenance and recall of memory T cells in peripheral tissueson March 1, 2009 at 4:00 am
However, memory T-cell transfer and parabiosis studies have shown that the migration of circulating memory T cells into some peripheral tissues, such as the skin, gut, lung airways and brain ...
via Bing News